Products
Research Areas
COVID-19
Resources
Login
Quick Order
Cart Cart lightblue
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Contact Us

Location


Corporate Headquarters

Vector Laboratories, Inc.
6737 Mowry Ave
Newark, CA 94560
United States

Telephone Numbers



Customer Service: (800) 227-6666 / (650) 697-3600


Contact Us



Additional Contact Details

Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Catalog Number Size Price
LS-C413515-100 100 µl (1 mg/ml) $321 
COXIV / COX4 Antibody - Immunofluorescent analysis of COX4-1 staining in HeLa cells. Formalin-fixed cells were permeabilized with 0.1% Triton X-100 in TBS for 5-10 minutes and blocked with 3% BSA-PBS for 30 minutes at room temperature. Cells were probed with the primary antibody in 3% BSA-PBS and incubated overnight at 4 deg C in a humidified chamber. Cells were washed with PBST and incubated with a FITC-conjugated secondary antibody (green) in PBS at room temperature in the dark. DAPI was used to stain the cell nuclei (blue).
COXIV / COX4 Antibody - Western blot analysis of COX4-1 expression in HeLa (A); HepG2 (B); 293T (C); mouse heart (D); mouse muscle (E); rat heart (F) whole cell lysates.
COXIV / COX4 Antibody - Immunofluorescent analysis of COX4-1 staining in HeLa cells. Formalin-fixed cells were permeabilized with 0.1% Triton X-100 in TBS for 5-10 minutes and blocked with 3% BSA-PBS for 30 minutes at room temperature. Cells were probed with the primary antibody in 3% BSA-PBS and incubated overnight at 4 deg C in a humidified chamber. Cells were washed with PBST and incubated with a FITC-conjugated secondary antibody (green) in PBS at room temperature in the dark. DAPI was used to stain the cell nuclei (blue).
COXIV / COX4 Antibody - Western blot analysis of COX4-1 expression in HeLa (A); HepG2 (B); 293T (C); mouse heart (D); mouse muscle (E); rat heart (F) whole cell lysates.
1 of 2
2 of 2

Monoclonal Mouse anti‑Human COXIV / COX4 Antibody (IF, WB) LS‑C413515

Monoclonal Mouse anti‑Human COXIV / COX4 Antibody (IF, WB) LS‑C413515

Antibody:
COXIV / COX4 Mouse anti-Human Monoclonal Antibody
Application:
ICC, IF, WB
Reactivity:
Human, Mouse, Rat
Format:
Unconjugated, Unmodified
Price
Catalog Number
$321
LS-C413515-100
Toll Free North America
(800) 227-6666
For Research Use Only

Overview

Antibody:
COXIV / COX4 Mouse anti-Human Monoclonal Antibody
Application:
ICC, IF, WB
Reactivity:
Human, Mouse, Rat
Format:
Unconjugated, Unmodified

Specifications

Description
COX4 antibody LS-C413515 is an unconjugated mouse monoclonal antibody to COX4 (COXIV) from human. It is reactive with human, mouse and rat. Validated for ICC, IF and WB.
Target
Human COXIV / COX4
Synonyms
COX4I1 | COX4-1 | COX4 | COX IV-1 | COXIV
Host
Mouse
Reactivity
Human, Mouse, Rat (tested or 100% immunogen sequence identity)
Clonality
Monoclonal
Conjugations
Unconjugated
Purification
Purified
Modifications
Unmodified
Immunogen
Recombinant protein corresponding to human COX4-1.
Specificity
Recognizes endogenous levels of COX4-1 protein.
Applications
  • ICC (1:100 - 1:200)
  • Immunofluorescence (1:100 - 1:200)
  • Western blot (1:1000 - 1:3000)
Presentation
PBS, pH 7.3, 0.01% Sodium Azide, 30% Glycerol
Storage
Aliquot and store at -20°C for 1 year. Avoid freeze/thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
About COXIV / COX4
P13073 NM_001861 NP_001852.1

Publications (0)

Customer Reviews (0)


Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at:

Technical.Support@LSBio.com

Requested From: United States
Date Requested: 12/27/2024